Event

8th Annual 340B Coalition Winter Conference

March 01, 2012

Morgan Lewis FDA & Healthcare partner Stephen Ruscus will be presenting on the panel titled "340 Policy and Compliance - Drug Supply Policy, Challenges, & Solutions" at the upcoming 8th annual 340B Coalition Winter Conference.

Topics to include:

  • Increased scrutiny of 340B program from Congress and government agencies.
  • Implications of Government Accountability Office report for providers, industry and HRSA.
  • Upcoming audits from the government and drug manufacturers.
  • Growing use of contract pharmacies and how to implement win-win partnerships.
  • A closer look how a user fee to fund 340B government operations would work.
  • Third party reimbursement trends and efforts by providers to challenge these contracts.
  • Implications of reductions in Medicaid reimbursement to 340B providers and efforts to design mutually beneficial arrangements.
  • Status of 340B legislation including extending 340B pricing to inpatient setting,  repeal of orphan drug discount restriction and exemption from 340B pricing on drugs in short supply.
  • Regulation defining scope of orphan drug discount restriction.
  • Possible congressional hearings on 340B program.
  • New guidance from HRSA when drug prices drop to a penny.

When:
Thursday, March 1, 2012
1:00 pm - 3:15 pm PT

Where:
Hotel del Coronado
1500 Orange Avenue
Coronado, CA 92118